These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 38742703)
1. Stimuli-Responsive Aptamer-Drug Conjugates for Targeted Drug Delivery and Controlled Drug Release. Zhu S; Gao H; Li W; He X; Jiang P; Xu F; Jin G; Guo H Adv Healthc Mater; 2024 Sep; 13(23):e2401020. PubMed ID: 38742703 [TBL] [Abstract][Full Text] [Related]
2. Advancing targeted combination chemotherapy in triple negative breast cancer: nucleolin aptamer-mediated controlled drug release. Ma Y; Xie D; Chen Z; Shen X; Wu X; Ding F; Ding S; Pan Y; Li F; Lu A; Zhang G J Transl Med; 2024 Jul; 22(1):604. PubMed ID: 38951906 [TBL] [Abstract][Full Text] [Related]
3. Improving Chemotherapy Effectiveness: Utilizing CuS Nanoparticles Coated with AS1411 Aptamer and Chitosan for Targeted Delivery of Doxorubicin to Cancerous Cells. Imanimoghadam M; Yaghoobi E; Alizadeh F; Ramezani M; Alibolandi M; Abnous K; Taghdisi SM J Pharm Sci; 2024 Jul; 113(7):1865-1873. PubMed ID: 38342338 [TBL] [Abstract][Full Text] [Related]
4. Nucleolin-Targeting AS1411 Aptamer-Modified Micelle for the Co-Delivery of Doxorubicin and miR-519c to Improve the Therapeutic Efficacy in Hepatocellular Carcinoma Treatment. Liang X; Wang Y; Shi H; Dong M; Han H; Li Q Int J Nanomedicine; 2021; 16():2569-2584. PubMed ID: 33833512 [TBL] [Abstract][Full Text] [Related]
5. Targeted co-delivery of FOXM1 aptamer and DOX by nucleolin aptamer-functionalized pH-responsive biocompatible nanodelivery system to enhance therapeutic efficacy against breast cancer: in vitro and in vivo. Masoudi M; Taghdisi SM; Hashemitabar G; Abnous K Drug Deliv Transl Res; 2024 Jun; 14(6):1535-1550. PubMed ID: 38161196 [TBL] [Abstract][Full Text] [Related]
6. Aptamer-Functionalized and Backbone Redox-Responsive Hyperbranched Polymer for Targeted Drug Delivery in Cancer Therapy. Zhuang Y; Deng H; Su Y; He L; Wang R; Tong G; He D; Zhu X Biomacromolecules; 2016 Jun; 17(6):2050-62. PubMed ID: 27113017 [TBL] [Abstract][Full Text] [Related]
7. Facile Construction of i-Motif DNA-Conjugated Gold Nanostars as Near-Infrared and pH Dual-Responsive Targeted Drug Delivery Systems for Combined Cancer Therapy. Miao D; Yu Y; Chen Y; Liu Y; Su G Mol Pharm; 2020 Apr; 17(4):1127-1138. PubMed ID: 32092274 [TBL] [Abstract][Full Text] [Related]
8. Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model. Moosavian SA; Abnous K; Badiee A; Jaafari MR Colloids Surf B Biointerfaces; 2016 Mar; 139():228-36. PubMed ID: 26722819 [TBL] [Abstract][Full Text] [Related]
9. Aptamer/Graphene Quantum Dots Nanocomposite Capped Fluorescent Mesoporous Silica Nanoparticles for Intracellular Drug Delivery and Real-Time Monitoring of Drug Release. Zheng FF; Zhang PH; Xi Y; Chen JJ; Li LL; Zhu JJ Anal Chem; 2015 Dec; 87(23):11739-45. PubMed ID: 26524192 [TBL] [Abstract][Full Text] [Related]
10. Synthesis of multimodal polymersomes for targeted drug delivery and MR/fluorescence imaging in metastatic breast cancer model. Zavvar T; Babaei M; Abnous K; Taghdisi SM; Nekooei S; Ramezani M; Alibolandi M Int J Pharm; 2020 Mar; 578():119091. PubMed ID: 32007591 [TBL] [Abstract][Full Text] [Related]
11. Aptamer-Aptamer Chimera for Targeted Delivery and ATP-Responsive Release of Doxorubicin into Cancer Cells. Esawi E; Alshaer W; Mahmoud IS; Alqudah DA; Azab B; Awidi A Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884745 [TBL] [Abstract][Full Text] [Related]
12. Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer. Zhuang J; Chen S; Hu Y; Yang F; Huo Q; Xie N Int J Nanomedicine; 2021; 16():1961-1976. PubMed ID: 33727809 [TBL] [Abstract][Full Text] [Related]
13. Legumain-cleavable 4-arm poly(ethylene glycol)-doxorubicin conjugate for tumor specific delivery and release. Zhou H; Sun H; Lv S; Zhang D; Zhang X; Tang Z; Chen X Acta Biomater; 2017 May; 54():227-238. PubMed ID: 28315495 [TBL] [Abstract][Full Text] [Related]
14. AS1411 Aptamer/Hyaluronic Acid-Bifunctionalized Microemulsion Co-Loading Shikonin and Docetaxel for Enhanced Antiglioma Therapy. Wang H; Zhu Z; Zhang G; Lin F; Liu Y; Zhang Y; Feng J; Chen W; Meng Q; Chen L J Pharm Sci; 2019 Nov; 108(11):3684-3694. PubMed ID: 31465736 [TBL] [Abstract][Full Text] [Related]
15. Enhanced cancer therapy with pH-dependent and aptamer functionalized doxorubicin loaded polymeric (poly D, L-lactic-co-glycolic acid) nanoparticles. Saravanakumar K; Hu X; Shanmugam S; Chelliah R; Sekar P; Oh DH; Vijayakumar S; Kathiresan K; Wang MH Arch Biochem Biophys; 2019 Aug; 671():143-151. PubMed ID: 31283911 [TBL] [Abstract][Full Text] [Related]
16. Dual pH/reduction-responsive hybrid polymeric micelles for targeted chemo-photothermal combination therapy. Zhang L; Qin Y; Zhang Z; Fan F; Huang C; Lu L; Wang H; Jin X; Zhao H; Kong D; Wang C; Sun H; Leng X; Zhu D Acta Biomater; 2018 Jul; 75():371-385. PubMed ID: 29777957 [TBL] [Abstract][Full Text] [Related]
17. Innovative gelatin-based micelles with AS1411 aptamer targeting and reduction responsiveness for doxorubicin delivery in tumor therapy. Yu J; Zhang Y; Xu M; Jiang D; Liu W; Jin H; Chen P; Xu J; Zhang L Biomed Pharmacother; 2024 May; 174():116446. PubMed ID: 38513599 [TBL] [Abstract][Full Text] [Related]
18. A Novel AS1411 Aptamer-Based Three-Way Junction Pocket DNA Nanostructure Loaded with Doxorubicin for Targeting Cancer Cells in Vitro and in Vivo. Taghdisi SM; Danesh NM; Ramezani M; Yazdian-Robati R; Abnous K Mol Pharm; 2018 May; 15(5):1972-1978. PubMed ID: 29669200 [TBL] [Abstract][Full Text] [Related]
19. Dual-Prodrug-Based Hyaluronic Acid Nanoplatform Provides Cascade-Boosted Drug Delivery for Oxidative Stress-Enhanced Chemotherapy. Zhang J; Deng M; Xu C; Li D; Yan X; Gu Y; Zhong M; Gao H; Liu Y; Zhang J; Qu X; Zhang J ACS Appl Mater Interfaces; 2024 Sep; 16(38):50459-50473. PubMed ID: 39258403 [TBL] [Abstract][Full Text] [Related]
20. AS1411 aptamer and folic acid functionalized pH-responsive ATRP fabricated pPEGMA-PCL-pPEGMA polymeric nanoparticles for targeted drug delivery in cancer therapy. Lale SV; R G A; Aravind A; Kumar DS; Koul V Biomacromolecules; 2014 May; 15(5):1737-52. PubMed ID: 24689987 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]